788 related articles for article (PubMed ID: 28657883)
21. The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb.
Landenberger M; Nieland J; Roeder M; Nørgaard K; Papatheodorou P; Ernst K; Barth H
Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183603. PubMed ID: 33689753
[TBL] [Abstract][Full Text] [Related]
22. The role of toxin A and toxin B in the virulence of Clostridium difficile.
Carter GP; Rood JI; Lyras D
Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
[TBL] [Abstract][Full Text] [Related]
23. (1)H(N), (13)C, and (15)N resonance assignments of the CDTb-interacting domain (CDTaBID) from the Clostridium difficile binary toxin catalytic component (CDTa, residues 1-221).
Roth BM; Varney KM; Rustandi RR; Weber DJ
Biomol NMR Assign; 2016 Oct; 10(2):335-9. PubMed ID: 27351891
[TBL] [Abstract][Full Text] [Related]
24. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
25. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
Davies AH; Roberts AK; Shone CC; Acharya KR
Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
[TBL] [Abstract][Full Text] [Related]
26. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
27. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
[TBL] [Abstract][Full Text] [Related]
28. The chaperonin TRiC/CCT is essential for the action of bacterial glycosylating protein toxins like
Steinemann M; Schlosser A; Jank T; Aktories K
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9580-9585. PubMed ID: 30181275
[TBL] [Abstract][Full Text] [Related]
29. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
Frädrich C; Beer LA; Gerhard R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
[TBL] [Abstract][Full Text] [Related]
30. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
Egerer M; Giesemann T; Herrmann C; Aktories K
J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
[TBL] [Abstract][Full Text] [Related]
31. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
[TBL] [Abstract][Full Text] [Related]
32. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
Antunes A; Dupuy B
Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
36. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
[TBL] [Abstract][Full Text] [Related]
38. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
39. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells.
Barth H; Stiles BG
Curr Med Chem; 2008; 15(5):459-69. PubMed ID: 18289001
[TBL] [Abstract][Full Text] [Related]
40. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
